MiRNA-128-3p Restrains Malignant Melanoma Cell Malignancy by Targeting NTRK3

Area of Science:

• Oncology
• Molecular Biology
• Gene Regulation

Background:

• Non-coding RNAs, particularly microRNAs (miRNAs), are increasingly recognized for their roles in cancer.
• Malignant melanoma (MM) is an aggressive skin cancer with complex molecular underpinnings.
• Understanding the specific functions of miRNAs in MM is crucial for developing targeted therapies.

Purpose of the Study:

• To investigate the role and molecular mechanisms of miR-128-3p in the biological behaviors of malignant melanoma.
• To determine the relationship between miR-128-3p and the expression of neurotrophin receptor 3 (NTRK3) in MM cells.

Main Methods:

• Quantitative analysis of miR-128-3p expression in MM cells.
• Assessment of cell proliferation, migration, invasion, and apoptosis.
• Luciferase reporter assays to confirm the binding of miR-128-3p to the NTRK3 3'-UTR.
• Experimental manipulation of miR-128-3p and NTRK3 levels.

Main Results:

• miR-128-3p was found to be expressed at low levels in MM cells.
• Overexpression of miR-128-3p inhibited MM cell proliferation, migration, and invasion, while promoting apoptosis.
• Neurotrophin receptor 3 (NTRK3) was upregulated in MM cells and acts as an oncogene.
• miR-128-3p directly binds to the 3'-UTR of NTRK3, suppressing its activity.
• miR-128-3p and NTRK3 exhibit synergistic and counteracting effects on malignant progression.

Conclusions:

• miR-128-3p functions as a tumor suppressor in malignant melanoma by inhibiting the oncogenic activity of NTRK3.
• The miR-128-3p/NTRK3 axis plays a significant role in modulating the malignant behavior of MM.
• Both miR-128-3p and NTRK3 represent potential therapeutic targets for MM treatment.